Carine Brouillon

Biography

Carine Brouillon is Global Commercial Strategy Leader for the Neuroscience Therapeutic Area. In this role, she directs the strategies and plans for Janssen Neuroscience pipeline products throughout the world. In partnership with Research & Development, Carine and her team are accountable for setting and executing the Neuroscience strategy, building disease area strongholds, maintaining the company's commercial strongholds, and developing deep areas of expertise in all commercial aspects. Her key areas of focus include market positioning of differentiated products and solutions, and development of global access strategies. In addition, Carine is chairperson of the Janssen Sustainability Council. She leads the Council in its work to build awareness and engagement among employees, integrate sustainability into Janssen's business practices, and advance the company's reputation for leadership in citizenship and sustainability. Carine joined Johnson & Johnson in 1997 as a product manager, and has held various positions of increasing responsibility in sales, marketing and general management. Previously, she served as President, Janssen Therapeutics. In this role, she was responsible for the United States commercial infectious diseases business, including driving growth for the company's HIV and hepatitis C medicines. She also served as a member of the Janssen North America Leadership Team.

Research Interest

Neuroscience